Pfizer Inc. (NYSE: PFE) and Valneva SE (NASDAQ: VALN; Euronext Paris: VLA) reported that their investigational Lyme disease vaccine candidate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE